Author:
Su Guozhu,Cao Yuan,Li Chun,Yu Xuelong,Gao Xiaoli,Tu Pengfei,Chai Xingyun
Abstract
Abstract
Genus Syringa, belonging to the Oleaceae family, consists of more than 40 plant species worldwide, of which 22 species, including 18 endemic species, are found in China. Most Syringa plants are used in making ornaments and traditional medicines, whereas some are employed for construction or economic use. Previous studies have shown that extracts of Syringa plants mainly contain iridoids, lignans, and phenylethanoids that have antitumor, antihypertensive, anti-oxidant, and anti-inflammatory activities. This study reviews phytochemical and pharmacological progress on Syringa in the recent 20 years and discusses the future research prospects to provide a reference in further promotion and application of the genus.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Editorial Committee of Chinese Material Medica. Chinese Material Medica-Mongolian volume. Shanghai Sci Technol Press. 1992;61:2–50.
2. Zhang JF, Zhang SJ. An overview of the genus Syringa: phytochemical and pharmacological aspects. Nat Sci J Hainan Univ. 2007;2:201–5.
3. Deng RX, Yuan H, Liu P, Yin WP, Wang XS, Zhao TZ. Chemical constituents from Syringa pubescens Turcz. Biochem Syst Ecol. 2010;38:813–5.
4. Zhang GB, Liu LJ, Wang MK. Chemical constituents of volatile oils from Syringa pinnatifolia. Chin Pharm J. 1994;5:271.
5. SamyK ED, GamalEldeen AM. Cytotoxic and anti-inflammatory activities of some constituents from the floral buds of Syringa patula. Pharm Biol. 2009;47:872–7.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献